Cytogen Corporation and Berlex Laboratories, a U.S. affiliate of Schering AG, Germany announced an agreement whereby marketing rights held by Berlex to market Quadramet (Samarium Sm 153 Lexidronam), a ...
Cytogen Corporation has completed the reacquisition of marketing rights held by Berlex Laboratories, a U.S. affiliate of Schering AG, Germany, to Quadramet (Samarium Sm 153 Lexidronam) in North and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results